Aptus Pharma IPO
GMP, Subscription, Price, Dates & Financial Details
Pharmaceutical & Drugs
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulationsThe company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain…
Open Date
Tue, 23 Sep 2025
Close Date
Thu, 25 Sep 2025
Price Band
₹ 65 – 70
Lot Size
200
Issue Size
₹ 13.02 Cr
Minimum Investment
₹ 28,000 (400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Aptus Pharma IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹13.02 Crore.
The Aptus Pharma IPO remained open for subscription from September 23, 2025, to September 25, 2025. The basis of allotment was finalized on September 26, 2025, and the company's shares were listed on BSE SME Platform on September 30, 2025.
The company had fixed the price band at ₹65 to ₹70 per share, with a lot size of 200 shares. Retail investors were required to make a minimum investment of ₹28,000 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Interactive Financial Services Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Aptus Pharma Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Aptus Pharma IPO Timeline (Tentative)
- IPO Open Date
- Tue, 23 Sep 25
- IPO Close Date
- Thu, 25 Sep 25
- Basis of Allotment
- Fri, 26 Sep 25
- Initiation of Refunds
- Mon, 29 Sep 25
- Credit of Shares to Demat
- Mon, 29 Sep 25
- Listing Date
- Tue, 30 Sep 25 — NSE & BSE
Open Date
23 September 2025
Close Date
25 September 2025
Basis Of Allotment
26 September 2025
Listing Date
30 September 2025
IPO Subscription
Check Live Subscription →The Aptus Pharma IPO has received bids for 2,77,30,000 shares against 12,38,000 shares offered, resulting in an overall subscription of 22.4x. the NII category is subscribed 29.11x, Retail Investors 31.54x, and QIBs 1.24x.
QIB
1.24x
NII
29.11x
RII
31.54x
Total
22.4x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 6,20,000 shares, representing 50.08% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 3,52,000 shares (28.43%), while Non-Institutional Investors (NIIs) receive 2,66,000 shares (21.49%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 352,000 | 28.43% |
| Non-Institutional | 266,000 | 21.49% |
| BNII | 178,000 | 14.38% |
| SNII | 88,000 | 7.11% |
| Retail Investors | 620,000 | 50.08% |
| Total | 1,238,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 21.92 | 10.03 | 6.22 |
| Revenue | 24.64 | 17.88 | 13.9 |
| Profit After Tax | 3.1 | 0.8 | 0.19 |
| Net Worth | 6.97 | 1.77 | 0.97 |
| Reserve & Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowings | 10.36 | 5.31 | 2.21 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Aptus Pharma Limited KPI Information
| Particular | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| ROE % | 44.5 | 45.18 | 20.06 |
| ROCE % | 45.66 | 21.7 | 12.77 |
| Debt / Equity | 1.49 | 3 | 2.28 |
| RoNW % | 44.5 | 45.18 | 20.06 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Aptus Pharma Limited | 10 | 0.00 | 5.32 | 5.32 | 44.50 | 13.93 |
| Zota health care limited | 10 | 382.12 | 3.16 | 3.16 | 2.72 | 110.83 |
| Sunrest Lifescience Ltd | 10 | 10.56 | 4.66 | 4.66 | 12.36 | 37.72 |
| Lincoln Pharmaceuticals Ltd | 10 | 13.53 | 41.11 | 41.11 | 12.26 | 335.34 |
About Aptus Pharma Limited
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
- Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.
- Aptus CD care: Focused on chronic therapies
- Aptus Wellcare: Offers wellness and nutraceutical products
- Aptus Global: Export in overseas market
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Aptus Pharma IPO Promoters
- Tejash Maheshchandra Hathi
- Chatrabhuj Vallabhbhai Butani
- Kapilbhai Hasmukhbhai Chandarana
- Ghanshyam Vinubhai Pansuriya
- Milly Chetan Lalseta
- Riddhish Natwarlal Tanna
- Gaurang Rameshchandra Thakker
- Kripaliben Mayank Thakker
- Kunjal Piyushbhai Unadkat
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
72.89%
Aptus Pharma IPO Objective
The Company Aptus Pharma IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Capital Expenditure for Office Premises with furniture and Industrial Racks
- Working Capital
- General corporate purposes
Aptus Pharma Limited Address / Contact Details
Aptus Pharma Ltd.
Ashutosh Buildcon, Opp. Slok - 2,
Nr. Harikrupa Logistic Park,
Aslali, Ahmedabad, Daskroi,
Ahmedabad, Gujarat, 382427
Phone: +91 76004 27827
Email: info@aptuspharma.com
Website: https://aptus-pharma.com/
IPO Snapshot
Aptus Pharma IPO Lot Size
The Aptus Pharma IPO has a lot size of 200 shares. Retail investors require a minimum investment of ₹2,80,000 by applying for 2 lot (4,000 shares). The maximum application allowed for the retail category is 2 lots (4,000 shares), requiring an investment of ₹2,80,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 4,000 | 280,000.00 |
| Retail (Max) | 2 | 4,000 | 280,000.00 |
| S-HNI (Min) | 3 | 6,000 | 420,000.00 |
| S-HNI (Max) | 7 | 14,000 | 980,000.00 |
| B-HNI (Min) | 8 | 16,000 | 1,120,000.00 |
Issue Reservation
- QIB — 28.43%
- NII — 21.49%
- RII — 50.08%
Book Running Lead Managers
- Interactive Financial Services Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Aptus Pharma IPO?
Aptus Pharma IPO is a Book-building IPO with a total issue size of ₹13.02 crore. The Aptus Pharma IPO price band is ₹65 to 70 per share. The Aptus Pharma IPO subscription opens on Tue, Sep 23, 2025, and closes on Thu, Sep 25, 2025. The Aptus Pharma IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Aptus Pharma IPO.
When will the Aptus Pharma IPO open for subscription?
The Aptus Pharma IPO opens on Tue, Sep 23, 2025 and closes on Thu, Sep 25, 2025
What is Aptus Pharma IPO Price Band?
Aptus Pharma IPO Price Band is ₹65 to 70 per share.
What is Aptus Pharma IPO Lot Size?
Aptus Pharma IPO lot size is 200 shares, Retail investors need a minimum investment of ₹28000 based on the upper price band
What is the minimum investment for Aptus Pharma IPO?
The minimum investment for Aptus Pharma IPO is ₹28000, based on one lot of 200 shares at the upper price band of ₹70 per share.
How to apply for Aptus Pharma IPO?
Investors can apply for the Aptus Pharma IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Thu, Sep 25, 2025. The application amount remains blocked until the Aptus Pharma IPO allotment is finalized.
What is Aptus Pharma IPO Issue Size?
Aptus Pharma IPO issue size is ₹13.02 crores.
What is the Aptus Pharma IPO Allotment Date?
Aptus Pharma IPO allotment date is Fri, Sep 26, 2025.
Who is the Aptus Pharma IPO Registrar?
The registrar for Aptus Pharma IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Aptus Pharma IPO allotment status, refund processing, and other IPO-related information.
What is the Aptus Pharma IPO GMP?
The Aptus Pharma IPO GMP (Grey Market Premium) is ₹4 as of Tue, Sep 30, 2025. Based on the upper price band of ₹70 per share, the estimated Aptus Pharma IPO listing price is ₹74, indicating a potential listing gain of approximately 5.71% over the issue price.
Who is the Aptus Pharma IPO Lead Manager?
The book-running lead managers (BRLMs) for the Aptus Pharma IPO are Interactive Financial Services Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Aptus Pharma IPO Red Herring Prospectus (RHP).